Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism.
SF-36
hyperparathyroidism
parathyroidectomy
quality of life
Journal
Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
01
02
2022
accepted:
23
02
2022
pubmed:
24
2
2022
medline:
24
2
2022
entrez:
23
2
2022
Statut:
epublish
Résumé
The extent of symptoms due to primary hyperparathyroidism (PHPT) depends on the population being studied. PHPT is mainly discovered incidentally through routine laboratory findings. Less is known about patient-experienced improvement following successful parathyroidectomy. The aim of our study was to assess the changes in the quality of life (QoL) after successful surgery using an SF-36 questionnaire. This is a prospective cohort study based on questionnaires. Forty consecutive patients diagnosed with PHPT were prospectively administered an SF-36 questionnaire before and 6 months after successful parathyroidectomy. A subgroup of 18 patients answered the questionnaire at 1 and 3 months after surgery. Successful surgery was based on biochemistry and pathology reports as confirmed by an endocrinologist. Results of each SF-36 subcategory were compared to the results at baseline in order to detect changes in patient-reported QoL after successful surgery. There were significant improvements in six of eight SF-36 subcategories: vitality (P = 0.0001), physical functioning (P = 0.04), general health perception (P = 0.004), physical role functioning (P = 0.04), social role functioning (P = 0.004), and mental health perception (P = 0.0001). Changes appeared within a month after surgery with no further significant changes at later time points. Parathyroidectomy significantly improves QoL as measured by a decrease in SF-36 scores as early as 1 month after successful parathyroidectomy. The SF-36 QoL questionnaire is suitable for monitoring changes in patient well-being after successful parathyroidectomy.
Identifiants
pubmed: 35196254
doi: 10.1530/EC-21-0630
pii: EC-21-0630
pmc: PMC9010815
doi:
pii:
Types de publication
Journal Article
Langues
eng
Références
Endocr J. 2021 Jan 28;68(1):87-93
pubmed: 32879163
Health Qual Life Outcomes. 2013 Jun 18;11:97
pubmed: 23777622
J Clin Endocrinol Metab. 2009 Jun;94(6):1951-8
pubmed: 19336505
J Clin Endocrinol Metab. 2016 Apr;101(4):1571-8
pubmed: 26771703
EJNMMI Phys. 2016 Dec;3(1):27
pubmed: 27837548
J Clin Epidemiol. 1998 Nov;51(11):991-9
pubmed: 9817117
World J Surg. 2007 Jun;31(6):1202-9
pubmed: 17460812
Surgery. 2021 Jan;169(1):114-119
pubmed: 32718801
Eur J Hybrid Imaging. 2021 Jul 6;5(1):13
pubmed: 34227025
Clin Endocrinol (Oxf). 2019 Jan;90(1):184-191
pubmed: 30267589
Diagnostics (Basel). 2020 Nov 19;10(11):
pubmed: 33228254
Surgery. 2009 Dec;146(6):1006-13
pubmed: 19958927
World J Surg. 2002 Aug;26(8):942-9
pubmed: 12016473
Lancet. 2009 Jul 11;374(9684):145-58
pubmed: 19595349
Aust J Physiother. 2007;53(3):208
pubmed: 17899676
J Nucl Med Technol. 2012 Jun;40(2):111-8
pubmed: 22454482